Editas Medicine, Inc. (EDIT)

Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	138.69	131.54	123.65	141.52	203.52	139.68
Short-Term Investments	82.27	138.37	199.46	202.75	296.33	262.43
Cash & Short-Term Investments	220.96	269.91	323.11	344.27	499.85	402.11
Cash Growth	-25.39%	-16.46%	-6.15%	-31.12%	24.31%	-12.04%
Accounts Receivable	0.51	16.27	10.19	5.15	0.27	6.05
Receivables	0.51	16.27	10.19	5.15	0.27	6.05
Prepaid Expenses	3.37	3.14	7.53	7.34	7.2	10.93
Total Current Assets	224.84	289.32	340.83	356.75	507.31	419.09
Property, Plant & Equipment	34.61	47.05	45.71	59.22	43.29	39.15
Long-Term Investments	-	-	104.02	93.1	120.07	109.66
Other Long-Term Assets	4.2	5.22	8.59	5.25	6.81	4.7
Total Assets	263.65	341.59	499.15	514.32	677.48	572.6
Accounts Payable	5.47	5.49	8.27	9.51	5.05	6.41
Accrued Expenses	16.95	44.1	34.56	31.3	20.19	24.05
Current Portion of Leases	13.16	14.65	12.16	11.08	10.31	6.81
Current Unearned Revenue	7	11.22	8.22	8.22	11.33	20.94
Other Current Liabilities	30.54	1.76	-	-	-	-
Total Current Liabilities	73.11	77.23	63.22	60.11	46.88	58.21
Long-Term Leases	17.97	20.38	24.37	32.86	16.07	19.32
Long-Term Unearned Revenue	103.78	106.64	60.67	60.67	60.89	73.98
Other Long-Term Liabilities	6.36	3.07	1.8	-	-	27.5
Total Liabilities	201.23	207.32	150.06	153.64	123.84	179.02
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,607	1,602	1,580	1,442	1,412	1,059
Retained Earnings	-1,545	-1,468	-1,231	-1,078	-857.7	-665.2
Comprehensive Income & Other	0.09	0.27	0.2	-3.6	-0.49	-0.05
Total Common Equity	62.42	134.27	349.1	360.68	553.64	393.59
Shareholders' Equity	62.42	134.27	349.1	360.68	553.64	393.59
Total Liabilities & Equity	263.65	341.59	499.15	514.32	677.48	572.6
Total Debt	31.13	35.03	36.54	43.95	26.38	26.14
Net Cash (Debt)	189.83	234.88	390.6	393.43	593.54	485.64
Net Cash Growth	-44.60%	-39.87%	-0.72%	-33.72%	22.22%	13.45%
Net Cash Per Share	2.30	2.85	5.14	5.73	8.78	8.29
Filing Date Shares Outstanding	83.71	82.98	81.81	67.47	68.46	67.24
Total Common Shares Outstanding	83.71	82.73	81.77	67.35	68.44	62.56
Working Capital	151.73	212.09	277.61	296.64	460.43	360.88
Book Value Per Share	0.75	1.62	4.27	5.36	8.09	6.29
Tangible Book Value	62.42	134.27	349.1	360.68	553.64	393.59
Tangible Book Value Per Share	0.75	1.62	4.27	5.36	8.09	6.29
Machinery	22.66	30.88	26.37	25.55	22.72	19.17
Construction In Progress	0.19	0.83	2.06	1.57	1.53	0.86
Leasehold Improvements	10.24	11.75	9.65	9.76	8.16	4.97

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q